Trial
NCT03187210
Brentuximab Vedotin and BeEAM High-dose Chemotherapy in Lymphomas
Phase ISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
Insel Gruppe AG, University Hospital Bern
Collaborators
Mundipharma Medical Company
Condition
Lymphoma
Intervention
Brentuximab Vedotin
Why stopped
low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-30